0001127602-18-024057.txt : 20180730
0001127602-18-024057.hdr.sgml : 20180730
20180730180925
ACCESSION NUMBER: 0001127602-18-024057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180726
FILED AS OF DATE: 20180730
DATE AS OF CHANGE: 20180730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GELBMAN RONALD G
CENTRAL INDEX KEY: 0001210616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 18978870
MAIL ADDRESS:
STREET 1: HAEMONETICS CORP
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184-9144
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0328
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-07-26
0000313143
HAEMONETICS CORP
HAE
0001210616
GELBMAN RONALD G
400 WOOD ROAD
BRAINTREE
MA
02184
1
Common Stock
2018-07-26
4
A
0
1696
A
57391
D
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest 100% on the first anniversary of the date of grant.
Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Gelbman
2018-07-30
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY
POWER OF ATTORNEY
For Executing SEC Securities Transaction Forms
Know all persons by these presents that the undersigned
hereby constitutes and appoints each of Michelle L. Basil,
Thomas V. Powers, Kristen Feetham and Laura Gallerane,
signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of
Haemonetics Corporation (the "Company"), Forms 3, 4 and 5
in accordance with Section 16(a) of the Securities Exchange Act
of 1934 and the rules thereunder and such other forms as may be
required by the United States Securities and Exchange Commission
(the "SEC") relating to transactions by the undersigned in
securities issued by the Company ("Forms");
(2) do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to
complete the execution of any such Forms, complete and
execute an amendment or amendments thereto, and timely
file such Forms with the SEC and any other appropriate
governmental authority; and
(3) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform all and every act and thing
whatsoever requisite, necessary and proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming any of the
undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file the Forms with respect
to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned
in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused his/her Power of
Attorney to be executed as of this 27th day of April, 2018.
/s/ Ronald G. Gelbman
Signature